Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA
Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA
Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA
Submitted by
admin
on December 15, 2017 - 9:36am
Source:
RAPS.org
News Tags:
Pfizer
biosimilars
Remicade
Ixifi
Inflectra
JNJ
Headline:
Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA
Do Not Allow Advertisers to Use My Personal information
